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The source, specificity, and plasticity of the forkhead
box transcription factor 3 (Foxp3)+ regulatory T (Treg)
and conventional T (Tconv) cell populations active at
sites of autoimmune pathology are not well charac-
terized. To evaluate this, we combined global reper-
toire analyses and functional assessments of iso-
lated T cell receptors (TCR) from TCRa retrogenic
mice with autoimmune encephalomyelitis. Treg and
Tconv cell TCR repertoireswere distinct, and autoan-
tigen-specific Treg and Tconv cells were enriched in
diseased tissue. Autoantigen sensitivity and fine
specificity of these cells intersected, implying that
differences in responsiveness were not responsible
for lineage specification. Notably, autoreactive Treg
and Tconv cells could be fully distinguished by an
acidic versus aliphatic variation at a single TCR
CDR3 residue. Our results imply that ontogenically
distinct Treg and Tconv cell repertoires with conver-
gent specificities for autoantigen respond during
autoimmunity and argue against more than limited
plasticity between Treg and Tconv cells during auto-
immune inflammation.
INTRODUCTION
The T cell-specific forkhead box transcription factor 3 (Foxp3)
endows T lymphocytes with regulatory activity (Fontenot and
Rudensky, 2005; Pacholczyk and Kern, 2008; Horwitz et al.,
2008; Tang and Bluestone, 2008). Foxp3+ regulatory T (Treg)
cells are critical for immune homeostasis, and Foxp3 deficiency
leads to overwhelming autoimmunity and early mortality. Treg
cells predominantly form as a separate lineage in the thymus.
Indeed, the TCR repertoires of Treg cells and conventional
Foxp3 T (Tconv) cells are largely distinct, though 10%–20%
of TCR sequences are shared between the populations (Hsieh
et al., 2006; Pacholczyk and Kern, 2008; Pacholczyk et al.,
2006). Peripheral interconversion between Treg and Tconv cellsIis also observed (Liang et al., 2005; Lathrop et al., 2008;
Coombes et al., 2007). Adaptive upregulation of Foxp3 has
been hypothesized to be an important mechanism limiting
inflammation-induced immunopathology.
During autoimmunity, Treg cells are often found in substantial
numbers within affected organs. Defects or deficiencies in Treg
cells have been identified in autoimmune patients, implicating
them in pathogenesis (Viglietta et al., 2004; Zhang et al., 2009;
Sugiyama et al., 2005). Adoptively transferred Treg cells can
ameliorate or abrogate even ongoing organ-specific autoimmu-
nity (Selvaraj and Geiger, 2008; Mekala et al., 2005; Tang and
Bluestone, 2006; Kohm et al., 2002; Zhang et al., 2004). Although
Treg cells may recognize foreign antigens, evidence indicates
that they also bear an overrepresentation of self-specific TCR,
and this self-specificity may be important for Treg cell restraint
of immunopathologic responses (Hsieh et al., 2004, 2006; An-
dersson et al., 2007; Romagnoli et al., 2002; Jordan et al.,
2001). Indeed, current evidence links specificity with Treg cell
activity. Autoantigen-specific TCR transgenic (Tg) Treg cells
are more potent than non-Tg Treg cells in downregulating
models of experimental allergic encephalomyelitis, gastritis,
and diabetes (Hori et al., 2002; Tang et al., 2004; O’Connor
and Anderton, 2008; Huter et al., 2008). Importantly, myelin auto-
antigen-specific Treg cells have been directly identified by
tetramer staining in the central nervous system (CNS) of mice
with experimental allergic encephalomyelitis (EAE) and have
been inferred in other studies (Korn et al., 2007; Yu et al., 2005;
Reddy et al., 2004, 2005). In contrast, studies of a model of auto-
immune uveitis failed to identify tissue specificity among
involved Treg cells (Grajewski et al., 2006) and one analysis of
Treg cell TCR specificity failed to find evidence for enhanced
self-specificity (Pacholczyk et al., 2007).
TCR repertoire analyses have shown utility in surveying over-
lap between Treg and Tconv cell populations (Lathrop et al.,
2008; Hsieh et al., 2004, 2006; Pacholczyk et al., 2006, 2007).
For example, in a diabetes model, only limited Treg and Tconv
cell overlap was seen in islets, suggesting that these cell types
were not interconverting at the site of inflammation (Wong
et al., 2007a). This type of analysis is powerful, though limited
in that inferences are made by population shifts in the absence
of specific knowledge about antigen reactivity. Likewise, studiesmmunity 31, 909–920, December 18, 2009 ª2009 Elsevier Inc. 909
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Repertoire and Response in EAEof antigen reactivity among Treg and Tconv cells have typically
been performed outside of the context of repertoire analyses
that illuminate relationships between T cell populations.
To clarify the specificity and responsiveness of Treg cells, their
relationship to effector T (Teff) cells during autoimmunity, and
ultimately their source—Foxp3 upregulation in Teff cells or
recruitment of a distinct regulatory population—we combined
both repertoire analysis and studies of a large cohort of individual
TCR. We developed a retroviral transgenic (retrogenic) mouse
model of EAE in which the TCRa chain locus is fixed by the
enforced expression of a TCRa from a myelin oligodendrocyte
glycoprotein (MOG)-specific T cell. Vb8.2 (TRBV13-2) is ex-
pressed by almost half of MOG-specific T cells in MOG-EAE
(Mendel et al., 1995), and we focused on this disease-associated
repertoire. Comparison of Vb8.2+ TCRb sequences indicated
that the Treg and Tconv cell TCR repertoires have limited overlap
within the periphery and CNS in mice with EAE. Further, shared
TCR were predominantly expressed by a single cell type, Treg or
Tconv cells. This argues against a primary influence for large-
scale interconversion between Treg and Tconv cells in shaping
CNS-infiltrating Treg and Teff cell responses. Isolation and
expression in T lymphocytes of a subset of TCR sequences
demonstrated marked enrichment of MOG-specific TCR in
Tconv cells and, to a lesser extent, Treg cells infiltrating the
CNS. Treg and Tconv cell TCR sensitivity and fine specificity
for MOG autoantigen were similar, suggesting that these did
not substantially influence T cell lineage assignment among
responding cells. Importantly, conserved CDR3b features were
associated with MOG specificity among the TCR analyzed. Inde-
pendent features reliably distinguished MOG-specific Treg and
Tconv cell TCR. These results demonstrate that the MOG-
specific Treg and Teff cell responses during EAE arise from pop-
ulations with different CDR3 imprints, identify only a more limited
potential for interconversion between these populations, and
suggest that cognate autoantigen sensitivity and presumably
affinity is not a primary driving force in the specification of
MOG-specific Treg cells responding in EAE. Implicitly, ontogeni-
cally distinct Treg and Tconv cell populations with convergent
specificity for autoantigen are involved in the autoimmune
response.
RESULTS
Retrogenic Mice Expressing a Single TCR Va Chain
We generated TCRa retrogenic mice (Holst et al., 2006) incorpo-
rating the a chain of the MOG35-55-specific 1MOG244.2 TCR
(Alli et al., 2008). TCRa cDNA was retrovirally transduced into
Tcra/, GFP-Foxp3 gene-targeted hematopoietic progenitor
cells (HPC), and these were adoptively transferred into suble-
thally irradiated Tcra/ mice. Because of the endogenous Ca
deficiency, all TCR incorporate the retrovirally encoded a chain;
germline TCRb freely rearranges.
At approximately 8 weeks post-HPC transfer, the retrogenic
mice showed good lymphoid engraftment. Thymocyte subsets
showed no significant differences (p > 0.05) compared with
C57BL/6 mice, though trended toward increased DN cells
(7.0% ± 6.8% 1MOG244.2a versus 3.0% ± 1.3% C57BL/6)
and decreased CD4+ SP cells (1.7% ± 1.8% versus 7.0% ±
3.8%) (Figure S1A available online). A mean of 83 ± 63 106 total910 Immunity 31, 909–920, December 18, 2009 ª2009 Elsevier Inc.splenic lymphocytes was seen, primarily B cells. Engrafted T
lymphocytes were decreased compared to C57BL/6 mice, and
comprised 9.7% ± 2.9% of lymphocytes in the lymph nodes
(LN) and 13.8% ± 4.9% in the spleen (Figures S1B and S1C;
C57BL/6 data available at http://www.jax.org). The CD4/CD8
ratio was elevated, 6.2 ± 1.3 in the lymph nodes (LN) and 10.0 ±
2.7 in the spleen compared with 1.6 in C57BL/6 mice (Fig-
ure S1D), indicating skewing of 1MOG244.2 TCRa T cells toward
the CD4+ T cell lineage. CD4+ T cells expressed the GFP-Foxp3
transgene in proportions comparable to that observed in wild-
type mouse strains, 12.8% ± 2.2% in LN and 7.5% ± 2.4% in
spleen. The 1MOG244.2a retrogenic mice developed EAE with
high penetrance after MOG35-55 immunization, with >90% of
mice developing typical disease symptoms (Figure S2). There-
fore mice expressing the 1MOG244.2a transgene develop a
repertoire that incorporates normal proportions of CD4+ Treg
and Tconv cells and are susceptible to EAE.
Increased TCR Vb8.2 in CNS-Infiltrating 1MOG244.2a
T Lymphocytes
As a low-resolution screen for EAE-associated alterations in the
1MOG244.2a TCR repertoire, we analyzed Vb chain use by
staining splenic or CNS CD4+ GFP-Foxp3 or GFP-Foxp3+ cells
with Vb-specific antibodies (Abs). Splenic T cell populations,
either Treg or Tconv, did not differ in unimmunized mice and
mice with EAE (Figures 1A and 1B). In contrast, a significant
increase in Vb8.1 or 8.2+ TCR use in CNS-infiltrating Tconv cells
was seen compared with splenic Tconv cells (Figure 1A;
p = 0.0135, ANOVA test; p = 0.018 after Hochberg’s adjustment
for multiple tests). This is consistent with the documented over-
representation of Vb8.2 among MOG35-55-A
b-specific Teff cells
(Mendel Kerlero de Rosbo and Ben-Nun, 1996; Mendel et al.,
1995). A trend toward increased Vb8.1 or 8.2 TCR use was
also seen among CNS Treg cells (Figure 1B), though not statisti-
cally significant. Therefore, Vb8.1- or 8.2-expressing T cells are
concentrated in the CNS during EAE, implying increased MOG
reactivity in the infiltrating T cell population.
TCR Jb and CDR3 Use in MOG-EAE
To examine the Treg and Tconv cell TCR repertoires at higher
resolution, we sacrificed 1MOG244.2a mice prior to immuniza-
tion or 23–25 days after EAE induction. Spleen and, for mice
with EAE, CNS cells were collected and pooled from 5–6 identi-
cally treated mice per group. Pooling was necessary because of
low postisolation T cell yields from the CNS of retrogenic mice.
The cells were sorted for CD4 and the presence or absence of
GFP-Foxp3, and cDNA were prepared. TCR cDNA was amplified
with Vb8.2-Cb primers to determine the distribution of Jb among
Vb8.2+ TCR. Individual amplicons were cloned, sequenced, and
analyzed for TCR gene use (Table 1). In total, 1829 sequences
were assessed with the Vb8.2-Cb primer set. Proportions of Jb
used by either the Foxp3+ or Foxp3 populations showed no
significant differences between the CNS and periphery in mice
with EAE (p > 0.05, not shown). Comparison of pre- and postim-
mune splenocytes also failed to identify changes in Jb use
among Foxp3+ T cells and showed a significant difference in
Foxp3 cells only for a single Jb, Jb2.4 (6.2% ± 0.5% pre versus
14.1% ± 0.5% post; p = 0.012). This indicates preserved diver-
sity in the Vb8.2+ population with EAE induction and when
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Figure 1. Vb Use by Retrogenic Treg and Tconv Cells
CD4+ T lymphocytes from retrogenic mice, preimmune or 22–28 days after EAE induction, were flow cytometrically analyzed with a panel of TCR Vb-specific
antibodies. Comparisons were made between Tconv (A) and Treg (B) cells from unimmunized and immunized splenocytes and CNS T cells from mice with
EAE. A significant increase in Vb8.1 or 8.2 splenocytes was seen among Tconv cells (p = 0.018), and a decrease in Vb8.3 TCR among Treg cells (p = 0.048)
when comparing pre- or immune splenic and CNS-infiltrating populations. Data show mean + 1 SEM. *p < 0.05 among group by Hochberg-adjusted 1-way
ANOVA.
Immunity
Repertoire and Response in EAEcomparing the CNS-infiltrating and splenic T cell populations of
diseased mice.
We next surveyed the more circumscribed Vb8.2-Jb2.7 reper-
toire. Jb2.7 was selected because of its use in the original
Vb8.2+Jb2.7+ TCRb chain partner of the 1MOG244.2a TCR (Alli
et al., 2008). Thus we knew that despite the theoretical potential
for formation of >106 unique TCR sequences with this Vb-Jb
constraint, Vb8.2+Jb2.7+ TCRb had the potential to pair with
the 1MOG244.2a to form MOG-specific TCR. In total, 2152
sequences were analyzed (Table 1). An estimated 95% confi-
dence interval for the upper limit of the maximum frequency
(4max) of unobserved TCR CDR3 sequences for individual cell
types and samples in different experiments ranged from 1.4%
to 3.1% (Table 1). Therefore the collected sequences were
adequate to assess common sequences in each cellular cohort.
Among the Vb8.2-Jb2.7 sequences obtained, 452 unique amino
acid sequences were identified. Interestingly, 54 (12%) of
these were shared among the 4 independent experiments orIpublic sequences. Public sequences were overrepresented
among more commonly identified sequences, with 74% of pub-
lic sequences present within the 100 most frequent sequences.
An increased probability of identifying sequences in multiple
independent samples when their sequence frequency is high is
expected and implies that the observed proportion of public
sequences underestimates total representation because of non-
identification of low-frequency public sequences. 16/54 public
sequences were found in TCR exclusively used by Treg cells,
14/54 in Tconv cell TCR, and 24/54 in sequences identified
both in Treg and Tconv cells. Abundance coverage estimator
analysis (ACE) of pooled sequences, an indicator of total
sequence diversity, indicated a limited diversity, with values of
271 and 337 for preimmune and 191 and 171 for postimmune
Vb8.2+, Jb2.7+ Tconv and Treg splenocytes, respectively. Inter-
estingly, the original b chain partner for the 1MOG244.2a TCR
was among the public sequences identified in the CNS Foxp3
populations of both EAE induction experiments, though not inmmunity 31, 909–920, December 18, 2009 ª2009 Elsevier Inc. 911
Table 1. Isolation of TCR Vb Sequences from Retrogenic Mice
Isolated Sequences
Experiment Disease Scores T Cell Type Vb-Cb Vb-Jb V-J fmax Upper 95% CI
1 (Preimmune) NA spleen Foxp3 total 137 155 2.25%
unique 131 55
spleen Foxp3+ total 152 183 1.91%
unique 150 64
2 (Preimmune) NA spleen Foxp3 total 102 161 2.17%
unique 97 54
spleen Foxp3+ total 128 123 2.85%
unique 124 62
3 (EAE, Day 23) 1,2,3,3,4 spleen Foxp3 total 159 167 2.09%
unique 97 52
spleen Foxp3+ total 131 141 2.48%
unique 57 46
CNS Foxp3 total 207 256 1.36%
unique 90 42
CNS Foxp3+ total 147 226 1.54%
unique 88 59
4 (EAE, Day 25) 1,1,1,2,2,2 spleen Foxp3 total 160 208 1.68%
unique 71 48
spleen Foxp3+ total 144 114 3.08%
unique 82 49
CNS Foxp3 total 207 211 1.65%
unique 82 45
CNS Foxp3+ total 155 207 1.68%
unique 60 41
For EAE studies, the day after immunization that analyses were performed and disease scores of individual mice studied are shown. Total numbers of
sequences isolated and numbers of unique amino acid sequences identified are listed for Vb8.2-Cb and Vb8.2-Jb2.7 analyses. The 4max confidence
interval (CI) refers to the upper frequency of a CDR3 sequence in the Vb8.2-Jb2.7 analysis for which there is 95% certainty of positive detection. NA, not
applicable.
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Repertoire and Response in EAEpreimmune analyses. This suggests that receptors relevant to
EAE in C57BL/6 mice, which served as the source of the original
1MOG244.2 hybridoma, play a role in the 1MOG244.2a retro-
genic mice.
Among public TCR, 20 CDR3 sequences were identified as
common to both preimmune T cells and T cells from mice with
EAE. TCR sequences appearing predominantly in Foxp3+ or
Foxp3 populations preimmune showed the same orientation,
Foxp3+ or Foxp3, in mice with EAE for 19 of the 20 receptors
(not shown). This implies that TCR sequence rather than disease
status is the primary force governing T cell Foxp3 expression.
Limited Overlap of Treg and Tconv Cell TCR Repertoires
Comparison of the unique CDR3 amino acid sequences for each
cellular cohort revealed several notable features. Repertoire
overlap was greater among a single class of cells (Treg or Tconv
cells) across different organs (spleen and CNS) than among
different classes of cells within an organ (Figure 2A). In experi-
ment 3 (Table 1), 32.7% of unique splenic and CNS Treg cell
TCR sequences and 23.9% of unique splenic and CNS Tconv
cell TCR sequences overlapped. In contrast, only 11.0% of
unique CNS and 10.1% of unique splenic sequences were
shared between Treg and Tconv cells. In experiment 4, the912 Immunity 31, 909–920, December 18, 2009 ª2009 Elsevier Inc.values were 20.0%, 27.4%, 14.7%, and 6.6%, respectively.
Further, among the minority of unique sequences that were
shared by Treg and Tconv cells, the isolates of a particular
sequence were typically skewed toward a single class of cells,
either Treg or Tconv cells. Indeed, the Treg/Tconv cell identifica-
tion ratio of shared TCR should form a Gaussian distribution,
potentially around a ratio of 1, if there was free and equal inter-
conversion between Treg and Tconv cells. Yet 73% of shared
CDR3 isolates were skewed by a ratio R2:1 toward a single
cell class (Figure S3A; mean, median for majority Foxp3+ TCR:
6.1 ± 7.3, 2.5; Foxp3 TCR: 9.1 ± 11.4, 5.1). This was influenced
by the presence of CDR3 for which few sequences were isolated,
and for which substantial skewing would therefore not be pos-
sible. Indeed, for shared sequences independently identified at
least 10 times, 84% had a ratioR2:1 (Figure S3B; mean, median
for Foxp3+: 9.3 ± 8.4, 9.1; Foxp3: 13.4 ± 13.8, 10.0). Skewing of
CDR3 toward a single cell class, Treg or Tconv cells, was also
readily apparent in graphical mapping of the distribution among
Foxp3+ or Foxp3 cells of the most common sequences isolated
in individual experiments (Figures S4 and S5) and in an ecologic
measure of population diversity, the Morisita Horn index, which
demonstrated strong dissimilarity in Treg and Tconv cell CDR3
sequences in either spleen or CNS and greater similarity when
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Figure 2. Population Differences among TCR Subsets in Mice with
EAE
(A) Unique TCR sequences from the identified experiments (Table 1) were
compared between population groups, and the frequency of sequences
shared by Treg and Tconv cells within an organ (left) or of sequences from
a specific cell type, Treg and Tconv cells, shared across organs (right) plotted.
(B) The Morisita-Horn index, a measure of ecologic diversity among popula-
tions, is plotted for the same groups as (A). A value of 1.0 indicates population
identity. Whereas (A) plots sharing of uniquely identified sequences, (B)
measures differences in both sequence diversity and identification frequency
between the indicated populations.
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Figure 3. Length, Charge, and Hydrophilicity of Isolated CDR3
Medians ± 95% CI for length (A), charge (B), and hydrophilicity (C) among
unique CDR3 sequences identified in the six indicated populations is plotted.
Analyzed sequences were determined as the regions bounded by but not
including the conserved C and F residues bordering each CDR3b. *p < 0.05
according to the Hochberg-adjusted Wilcoxon rank sum test.
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Repertoire and Response in EAEan individual cell type was compared between spleen and CNS
(Figure 2B).
Comparative analyses were further performed on three struc-
tural features of the identified CDR3, length, charge, and hydro-
philicity as potential correlates of specificity (Figure 3). The six
cohorts of unique CDR3 sequences, acquired from postimmune
CNS, postimmune spleen, and preimmune spleen Foxp3+ and
Foxp3 cells, were compared via the Kruskal-Wallis test and
significance was observed only for charge (p < 0.0001). With
the Wilcoxon rank-sum test to compare any two cohorts within
this group, the charge of the CNS Foxp3 CDR3 showed signif-
icant differences with each of the five other cohorts (p% 0.02 for
all comparisons after Hochberg’s adjustment for multiple tests).
A significant difference was seen in only one other comparison
group, CNS and preimmune splenic Foxp3+ CDR3 (p = 0.019).
Therefore, CNS-infiltrating T cells, particularly Foxp3 cells,
possess at least one distinguishing CDR3 characteristic,
increased negative charge. Of note, the MOG35-55 epitope this
CDR3 engages bears a potentially complementary positive
charge and includes three arginine residues, two of which are
predicted to lie in the Ab binding groove with their guanidinium
moieties directed toward the TCR (Ben-Nun et al., 2006).IIn summary, these results demonstrate distinct Treg and
Tconv cell TCR repertoires in EAE in the CNS and periphery.
Some overlap (10%) was observed between CDR3 from the
populations, though this was less than the overlap among a
single class of cells, Treg or Tconv cells, compared in the spleen
and CNS. Among CDR3 shared by Treg and Tconv cells, indi-
vidual sequences tended to be dominantly represented within
a single cell type. These results and the identification of distinct
charge characteristics specifically among CNS-infiltrating Tconv
cells implies that Treg and Tconv cells in EAE are distinct popu-
lations and do not substantially interconvert.
MOG Specificity among Treg and Tconv Cell TCR
To better delineate the properties of the responding TCR present
within the CNS and periphery during EAE, we recreated full-length
ab TCR cDNAs from 40 identified CDR3 sequences (Table 2). The
CDR3 were selected from sequences identified at high frequency
(all were among the 50 most commonly identified sequences) to
provide an approximately equal distribution of predominantly
Foxp3+ and Foxp3 CDR3 of splenic or CNS origin. As above
(Figures S3–S5), TCR with sequences shared by both Treg and
Tconv cells were heavily skewed toward a single cell class
(Table 2, far right column). A high representation of public TCRmmunity 31, 909–920, December 18, 2009 ª2009 Elsevier Inc. 913
Table 2. Features of CDR3b Used to Reconstitute Full-Length TCR cDNA
Immunity
Repertoire and Response in EAEwas seen among the selected CDR3 (21/40 sequences), reflect-
ing the increased frequency of these sequences among common
TCR. Reconstituted TCR were subcloned into a tricistronic retro-
viral vector essentially as we have previously described (Alli et al.,
2008), with TCR a and b chains linked by the Thosea asigna virus
2A sequence to facilitate their stoichiometric expression and an914 Immunity 31, 909–920, December 18, 2009 ª2009 Elsevier Inc.IRES-linked cyan fluorescent protein (CFP). TCR-encoding retro-
virus for these and the original 1MOG244.2ab TCR were trans-
duced into the CD4+ TCRab-deficient 4G4.CD4 T cell line. The
cells were flow cytometrically sorted for similar TCR expression
levels and stimulated with MOG35-55 peptide, and IL-2 production
was measured as an indicator of MOG responsiveness.
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Figure 4. MOG Specificity among Isolated TCR
Forty CDR3b, distributed among Foxp3+ and Foxp3 isolates from the CNS or spleen, were used to construct retrovirus incorporating full-length ab TCR. Retro-
virally transduced 4G4.CD4 T cells were flow cytometrically sorted for similar surface expression of TCR and stimulated with Tcra/ splenic APC with or without
100 mg/ml MOG35-55 peptide or with plate-bound CD3 antibody. IL-2 production was measured in cell-free supernatant at 24 hr by ELISA. Data indicate mean + 1
SEM and are representative of three or more assays for each TCR.
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Repertoire and Response in EAEMOG specificity varied among the TCR cohorts (Figure 4).
2/12 (16.7%) of splenic Foxp3 TCR from immunized mice re-
sponded to MOG, whereas 1/8 (12.5%) of splenic Foxp3+ TCR
responded. In contrast to this more modest representation of
MOG-specific cells in the periphery, 8/8 (100%) of CNS Foxp3
and 6/12 (50%) of CNS Foxp3+ TCR-transduced cells produced
IL-2 in response to MOG. These results therefore demonstrate
substantial enrichment of MOG specificity within CNS-infiltrating
Tconv cells of mice with EAE. Further, despite the evidence from
our repertoire analyses for limited interconversion between
Tconv and Treg cells and the use of a TCRa in the retrogenics
derived from a Foxp3 T cell, a substantial proportion of the
Treg cell response was directed against MOG.ISegregation of MOG-Specific Treg and Tconv Cell TCR
Based on CDR3b Characteristics
Sequence information for all MOG-specific and nonspecific TCR
was compared (Table 2). This provided several insights. First,
MOG-specific CDR3b, Foxp3+ or Foxp3, bore a consistent
length of 12 (11.9 ± 0.8; 15/18 [83%] sequences length of 12).
The non-MOG-specific TCR showed only slightly decreased
average length (11.2 ± 1.6), but many fewer 12 amino acid
sequences (5/23; 23%) and more diversity in this measure.
MOG-specific TCR further more consistently had a G at the 6th
CDR3 position (16/18; 89%) compared with non-MOG-specific
TCR (4/23; 17%), implying that the absence of a side chain in that
position is important for antigen recognition. More interestingly,mmunity 31, 909–920, December 18, 2009 ª2009 Elsevier Inc. 915
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Figure 5. Sensitivity of MOG35-55-Specific TCR for Autoantigen
Cells bearing the indicated Foxp3 (A) or Foxp3+ (B) T cell-derived TCR were
analyzed as in Figure 3 but stimulated with varied doses of MOG35-55 peptide.
All cell lines were simultaneously analyzed for comparability. Data show
mean ± SEM and are representative of three independent experiments with
at least two independent transductions of each TCR.
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Repertoire and Response in EAEamong the MOG-specific TCR, CDR3 sequence distinguished
TCR derived from primarily Foxp3+ and Foxp3 T cells. Acidic
D or E residues were present at position 4 in 11/11 (100%) of
Foxp3 but 0/7 (0%) of Foxp3+ MOG-specific CDR3. D and E
would be anticipated to have a high prevalence at this location;
a D is formed with Vb8.2-Db recombination in the absence of
junctional mutations or with a C/T replacement at the first
D-region nucleotide. An E is formed with a C/A or G replace-
ment at the same nucleotide. Indeed, 5/10 (50%) of Foxp3
and 8/13 (62%) of Foxp3+ nonspecific CDR3 bore a D or E at
position 4, making its complete absence more surprising in
the Foxp3+ MOG-specific population. In contrast, 100% of the
MOG-specific Foxp3+ TCR bore an aliphatic A (4/7), V (2/7), or
L (1/7) residue at that location, residues seen in only 1 of
the 34 other CDR3 examined. Therefore, TCR expressed by
MOG-specific Treg and Tconv cells comprise distinct families.
Implicitly, these cells undergo a distinct selection process in
1MOG244.2a mice that is either not based on MOG recognition
or is based on differential recognition of MOG.
Sensitivity and Fine Specificity of MOG-Specific TCR
for Autoantigen
Current models of Treg cell lineage specification suggest that
Treg cells possess a proclivity for self-reactivity and that thymo-
cytes with higher affinity for self-antigen are diverted into the
Foxp3+ lineage (Pacholczyk and Kern, 2008). MOG is expressed
in the thymus, though in small amounts (Delarasse et al., 2003).
If MOG is responsible for the selection of MOG-reactive Treg
cells, then these cells would be anticipated to bear an increased
affinity for it. Because the 4G4.CD4 TCR transductants were
essentially identical except for the sequence of their TCR
CDR3b, their relative sensitivity to Ag should primarily reflect their
affinity. We therefore tested the sensitivity of all MOG-specific
TCR to dilutions of MOG35-55 peptide (Figure 5). Interestingly,
although Treg cell TCR trended toward increased sensitivity,
substantial overlap was observed between the MOG-specific
Treg and Tconv cell TCR. In each case, receptors were identified
with high, moderate, and low sensitivity for MOG. Moreover,
specific pairs of Foxp3+ and Foxp3 CDR3 with conserved
amino acid sequences showed similar sensitivities for antigen
(Table 2 and Figure 5). Clones 19 (Foxp3) and 1 (Foxp3+), which
besides the variation at position 4 only have a conserved V/L
substitution at position 8, both responded vigorously to MOG
stimulation. Clones 45 (Foxp3) and 52 (Foxp3+), which differ
only at position 4 and by a S/G at position 7, also responded
similarly and more moderately. Therefore, although Treg cells
tend toward increased sensitivity for MOG, this does not seem
to be encoded into the position 4 variation and a MOG sensitivity
threshold does not appear fundamental to response by Treg
versus Tconv cell TCR.
These results suggest that other factors affected by the posi-
tion 4 variation, for instance differential fine specificity for MOG
or sensitivity to an alternative cross-reactive selecting Ag(s),
are responsible for Treg cell lineage assignment. To test the
former possibility, we examined the fine specificity of recognition
of five of the MOG-specific Foxp3 TCR, including the index
1MOG244.2 TCR, and four of the Foxp3+ TCR. Prior studies
with MOG35-55-specific TCR have identified critical TCR interact-
ing residues, particularly R41, F44, R46, and V47 (Petersen et al.,916 Immunity 31, 909–920, December 18, 2009 ª2009 Elsevier Inc.2004). The different TCR demonstrated variability, through com-
mon patterns of reactivity when tested with alanine-substituted
MOG35-55 peptides (Figure S6). An R41A substitution did not
substantially influence recognition for 1MOG244.2 or most of
the other TCR, whereas response was diminished to F44A,
R46A, and V47A substitutions. However, with these and alanine
substitutions at all residues from V37 to L50, no pattern was
identified that distinguished the fine specificity of the Foxp3+
and Foxp3 T cell-derived TCR. Therefore, differential recogni-
tion of cognate MOG antigen does not appear to be associated
with the binary differentiation of T cells with acidic or aliphatic
residues at CDR3b position 4 alternatively into Tconv or Treg
cells. Considering the absence of evidence for affinity or fine
specificity-based segregation of Tconv and Treg cell TCR, our
data would suggest that a MOG sensitivity threshold is not itself
responsible for MOG-specific Treg cell recruitment, and presum-
ably also lineage assignment.
Fidelity in TCR Lineage Specification
The 1MOG244.2a retrogenic mice were produced with Tcra/
HPC and recipient mice. We were interested whether the
MOG-specific Treg and Tconv cell TCR that we identified in
1MOG244.2a mice (Table 2) would similarly guide differentiation
in a distinct system where the thymus is from a wild-type and not
Tcra/ mouse and most developing T cells are unmanipulated.
To test this, we transduced MOG-specific TCRab pairs into
CD45.1CD45.2+ Rag1/ HPC, which cannot express other
TCR. These were diluted with an excess of congenic CD45.1+
CD45.2 T cell-depleted bone marrow cells and transplanted
into CD45.1+CD45.2 mice. Seventeen mice demonstrated
detectable CD45.2+CD4+ T cell engraftment (range 0.001%–
8.5% of CD4+TCR+ cells), including mice expressing three TCR
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Repertoire and Response in EAEderived from Treg cells (#1, 9, 18; Table 2) and four from Tconv
cells (#2, 6, 21, 45) (Figure S7). Overall, the Treg cell-derived
TCR showed >20-fold increased engraftment into the Foxp3+
lineage when compared with the Tconv cell TCR (mean of
Foxp3+ cells: 21.4% ± 10.6%; of Foxp3 cells: 0.95% ± 1.1%).
Therefore, cells expressing TCR derived from Tconv cell TCR
in 1MOG244.2a mice differentiate into Tconv and not Treg
cells in this system. Cells expressing TCR derived from Treg
cell TCR in 1MOG244.2a mice show increased Treg cell bias.
Although not all of the retrogenic T cells expressing the Treg
cell-derived TCR developed into Foxp3+ cells, this is not sur-
prising because niche saturation for Treg cell development
may occur even at very small numbers of Ag-specific T cells
(Bautista et al., 2009). Despite heavy dilution with wild-type cells
in these mixed chimeric mice, cells expressing the assayed TCR
should nevertheless be increased in frequency compared with
1MOG244.2a mice. Therefore, Treg and Tconv cell lineage
assignment in the 1MOG244.2 TCRa retrogenic mice is paral-
leled in a distinct and arguably more natural system, one in which
the thymic stroma and the large majority of T cells are wild-type.
DISCUSSION
Treg and Tconv cells in naive mice bear distinct though overlap-
ping repertoires (Hsieh et al., 2004, 2006; Pacholczyk et al.,
2006; Pacholczyk and Kern, 2008; Wong et al., 2007b). Studies
of adoptively transferred purified CD4+ T cells have indicated
variable interconversion rates between Foxp3 and Foxp3+ pop-
ulations (Lathrop et al., 2008; Fontenot et al., 2005; Liang et al.,
2005). One recent analysis estimated a 4%–7% rate of Foxp3
upregulation after naive T cell transfer and identified a key role
for TCR sequence and hence specificity in this (Lathrop et al.,
2008). Mechanistic studies have provided a framework explain-
ing plasticity between Treg and Tconv cells, with select signaling
pathways regulating Foxp3 expression (Coombes et al., 2007;
Quintana et al., 2008; Mucida et al., 2007; Selvaraj and Geiger,
2007). The extent to which interconversion influences active
immune responses, and more specifically cells participating in
autoimmunity, is uncertain. Some results suggest that adaptive
upregulation of Foxp3 plays an important role in modulating
autoimmunity (You et al., 2007; Manicassamy et al., 2009). Other
studies failed to identify a role for Foxp3 induction (Korn et al.,
2007; Wong et al., 2007a). During EAE, T cells activated in the
periphery migrate to the CNS where they re-engage antigen on
local dendritic cells and expand (Bailey et al., 2007). The early
CNS response has a low frequency of Foxp3+ T cells, suggesting
that substantial numbers of Treg cells are not stimulated to enter
the CNS at this time. Yet Treg cells accumulate later in the
disease and are associated with resolution (McGeachy et al.,
2005). Therefore, either migration or expansion of this population
is delayed or CNS-infiltrating Treg cells are forming through Teff
cell conversion.
At a population level, our data fail to identify a substantial role
for interconversion as a means of locally generating Treg cells in
the CNS. The frequencies of shared CDR3 among unique TCR
sequences in preimmune splenocytes (expt 1: 3.5%; expt 2:
6.4%) was only modestly lower than that in postimmune spleno-
cytes (expt 3: 10.1%, expt 4: 6.6%). The difference between
postimmune splenocytes and CNS-infiltrating cells (expt 3:I11%, expt 4: 14.7%) was likewise small. These trends may be
consistent with limited interconversion between Treg and Tconv
cell lineages; however, this and the heavy skewing of shared
TCR toward a single cell type argue against extensive plasticity
in Foxp3 expression during EAE.
Analysis of select receptors provided added insight into the
composition of the autoreactive Treg and Teff cell responses.
MOG-specific Teff cells were highly enriched in the CNS of
1MOG244.2a mice with EAE (100% of TCR). This contrasts with
a low frequency (<10%) of MOG-specific CNS-infiltrating cells
identified in a study with MOG-Ab tetramer, potentially reflecting
our focus on a subpopulation of TCR (Vb8.2+Jb2.7+) that may
tend toward MOG specificity. However, we were also unable to
stain some MOG-specific T cells with an essentially identical
tetramer, including the 1MOG244.2 TCR studied here, suggesting
that this tetramer may underestimate the actual frequency of
MOG-specific cells (R. Alli and T.L.G., unpublished observations).
More interestingly, we identified a concentration of MOG-
reactive TCR among the CNS-infiltrating Foxp3+ population
(50% versus 12.5% among Foxp3+ splenocytes). This function-
ally confirms the presence of cognate autoantigen-reactive Treg
cells in the CNS of mice with EAE at high frequency. Unlike Teff
cells, which were uniformly MOG specific, 50% of Vb8.2+Jb2.7+
Treg cell TCR tested did not recognize MOG. These cells may be
bystanders or effectors specific for alternative antigens. Indeed,
Treg cells need not be specific for cognate autoantigen, and
response toward tissue-specific or even tissue-unrestricted
self antigens released during inflammation may potentially stim-
ulate regulatory functions.
Among the MOG-specific T cells, a length of 12 amino acids
and a G at position 6 in the Vb8.2+Jb2.7+ CDR3b was highly
correlated with MOG specificity. Importantly, MOG-specific
Teff cells during EAE were fully distinguished by a D or E at posi-
tion 4, and Treg cells by an aliphatic residue, most commonly an
A. Implicitly, Treg and Teff cells during autoimmunity arise from
distinct population reservoirs, identifiable by the variation at
residue 4. Additional structural criteria overlayed on this must
be met for MOG specificity. It would seem likely that these
distinct populations arise from differences in the origination
and selection of the T cells.
Expression of high-affinity cognate antigen on thymic stroma
promotes enhanced Treg cell differentiation for some TCR (Picca
et al., 2006). MOG is expressed at low levels in the thymus
(Delarasse et al., 2003). If MOG sensitivity guides Treg cell devel-
opment, these cells should be more sensitive to MOG than Teff
cells. Overall, Treg cell TCR showed higher MOG sensitivity
than did Teff cell TCR. However, the substantial overlap in
Treg and Teff cell TCR sensitivity implies that this is not funda-
mental to their selection. Further, differential fine specificity for
MOG was not identified in Treg and Teff cell TCR. The simplest
explanation for the similar MOG response yet different and
conserved CDR3 features of Treg and Teff cell TCR is that
lineage selection for the corresponding cell types is not MOG
dependent, but rather that alternative Ag(s) promote selection.
Recognition of the acidic versus aliphatic variation in Tconv
and Treg cell CDR3 was possible only by examining a narrow
slice of the repertoire, one with a fixed TCRa and limited to
Vb8.2 and Jb2.7. This focused repertoire analysis required the
production and study of a manipulated mouse strain, themmunity 31, 909–920, December 18, 2009 ª2009 Elsevier Inc. 917
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specific public TCR within Treg or Tconv cell repertoires in these
mice indicates consistency in T cell differentiation patterns within
them. However, the 1MOG244.2a mice do use a Tcra/ stem
cell recipient, whose thymi developed in the absence of normal
T cell maturation. Further, premature expression of TCRa in
transgenic or retrogenic systems, such as 1MOG244.2a mice,
can influence pTa signaling and decrease the efficiency of the
DN to DP transition, potentially altering the balance of different
thymocyte subsets (Huang and Kanagawa, 2004; Borowski
et al., 2004; Aifantis et al., 2006). We do not find evidence for
these alterations influencing Treg cell lineage assignment.
Grossly, proportions of Treg cells are normal in 1MOG244.2a
mice, and overlap among Treg and Tconv cell TCR is similar to
that observed in other systems (Hsieh et al., 2006; Pacholczyk
et al., 2006). More importantly, precursor cells retrogenic for
specific Treg or Tconv cell TCR, when heavily diluted with
wild-type bone marrow and transplanted into wild-type mice,
show the same lineage predilection as in 1MOG244.2a mice.
This suggests that TCR-driven Treg and Tconv cell lineage spec-
ification in 1MOG244.2amice is indicative of the potentials of the
same TCR in normal thymi as well.
In summary, we demonstrate through studies of repertoire and
individual TCR only limited overlap between Treg and Tconv cells
responding during MOG-EAE. MOG-specific Treg cells form
a substantial though not exclusive component of the CNS-infil-
trating Treg cell repertoire. Examination of MOG-specific Treg
and Teff cell TCR with a fixed TCRa and restricted TCRb usage
fails to find evidence for sensitivity or fine specificity for MOG
influencing Treg versus Tconv cell lineage assignment, but
does reveal lineage segregation based on conserved CDR3
features. Our results favor a model in which Treg cell response
during EAE is developmentally encoded in the TCR repertoire
and argue against anything more than limited plasticity between
Treg and Tconv cells during the autoinflammatory response.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 and Tcra–/– mice were obtained from The Jackson Laboratory (Bar
Harbor, ME). GFP-FoxP3 gene-targeted mice were provided by A. Rudensky
(U. Washington). Mice were bred under specific-pathogen-free, including all
detectable strains of Helicobacter, conditions. Experiments were performed
in accordance with institutional animal care and use procedures.
Peptides, Antibodies, and Flow Cytometry
MOG35-55 peptide (MEVGWYRSPFSRVVHLYRNGK) and alanine substitutions
of it were synthesized by the St. Jude Hartwell Center for Biotechnology and
HPLC purified prior to use. Monoclonal antibodies specific for CD4 (clone
L3T4), CD8 (clone 53-6.7), CD25 (clone 7D4), TCRb (clone H57-597), TCR
Vb2 (clone B20.6), TCR Vb3 (clone KJ25), TCR Vb4 (clone KT4), TCR Vb5.1,
5.2 (clone MR9-4), TCR Vb6 (clone RR4-7), TCR Vb7 (clone TR310), TCR
Vb8.1 and 8.2 (clone MR5-2), TCR Vb8.3 (clone 1B3.3), TCR Vb10b (clone
B21.5), TCR Vb11 (clone RR3-15), TCR Vb12 (clone MR11-1), and TCR Vb14
(clone 14-2) were obtained from BD Biosciences. Flow cytometry was per-
formed on a FACS Calibur (BD Biosciences), and flow cytometric sorting
was on a MoFlo (DakoCytomation) or iCyt reflection (iCyt, Champaign, Ill)
cell sorter.
Retroviral TCR Construct Synthesis
To generate the 1MOG244.2 TCRa construct, the 1MOG244.2 TCRa (Alli et al.,
2008) was PCR amplified and inserted into EcoRI/XhoI cloning sites in the918 Immunity 31, 909–920, December 18, 2009 ª2009 Elsevier Inc.MSCV-I-CFP vector (Persons et al., 1997). To generate other TCR, we ampli-
fied and TA cloned CDR3b cDNA isolated during repertoire analyses with
primers incorporating an endogenous Vb8.2 BamHI site and inserting a XhoI
restriction site within the Cb (50 primer: GGTGCTGGATCCACTGAGAAAGGA
GATATCCC; 30 primer: GCCTCGAGAACCGTGAGCCTGGTGC). The intro-
duced XhoI site did not alter amino acid sequence. The cDNA were then subcl-
oned into the previously described 1MOG244.2ab MSCV-I-CFP vector (Alli
et al., 2008) modified with the Quick change site directed mutagenesis kit
(Stratagene) to incorporate the XhoI. Construct integrity was verified by DNA
sequencing.
Retrovirus Production and Cellular Transduction
Retrovirus transduction of hematopoietic progenitor cells (HPC) or murine
surface TCR-deficient 4G4.CD4 T hybridoma cells was as previously
described (Alli et al., 2008).
Generation of Retrogenic Mice
Bone marrow cells were harvested from the femurs of Tcra–/– mice 48 hr after
the administration of 0.15 mg 5-fluorouracil g1 body weight, cultured in
complete Click’s medium (Invitrogen) with 20% FCS, IL-3 (20 ng ml1), IL-6
(50 ng ml1), and stem cell factor (50 ng ml1) for 48 hr and then cocultured
for an additional 48 hr with irradiated (1200 rad) GP+E86 retrovirus producer
cells. Transduced progenitor cells were harvested, washed with PBS, trans-
duction confirmed by flow cytometry for CFP, and injected into sublethally irra-
diated (450 rad) Tcra–/– recipients at a ratio of 1.5 recipient mice per bone
marrow donor.
EAE Induction and Clinical Evaluation
EAE was induced by subcutaneous immunization of mice 8–10 weeks post-
stem cell transfer with 100 mg of MOG35–55 peptide in complete Freund’s adju-
vant containing 0.4 mg Mycobacterium tuberculosis H37RA (Difco). 200 ng
pertussis toxin (List Biological Laboratories) was administered i.v. on days
0 and 2. Clinical scoring was: 1, limp tail; 2, hind limb paresis or partial paral-
ysis; 3, total hind limb paralysis; 4, hind limb paralysis and body or front limb
paresis or paralysis; 5, moribund.
Cell Isolation
At the indicated time points, 5–6 mice per cohort were sacrificed, spleens were
removed, the circulation was perfused with PBS, and brain and spinal cord
removed. T cells were isolated from CNS tissue by density centrifugation as
described (Selvaraj and Geiger, 2008). Isolated cells were flow cytometrically
analyzed with the indicated antibodies or stained with CD4-specific Ab and
immediately sorted into Tconv cell (CD4+GFP) and Treg cell (CD4+GFP+)
populations.
RNA Isolation and cDNA Transcription
Total RNA was extracted with the RNeasy Protect MiniKit (QIAGEN). cDNA
was generated with the Omniscript RT kit (QIAGEN).
CDR3 Sequencing and Analysis
cDNA was PCR amplified with either Cb- or Jb2.7-specific primers (Cb, 50-CAA
GGAGACCTTGGGTGGAGTCACATT; Jb2.7, 50-TAAAACCGTGAGCCTGGTG
CCGG) and a Vb8.2 primer (Vb8.2, 50-ATGTCTAACACTGCCTTCCCTGACCC).
Five independent PCR reactions were performed with each sample per primer
pair. The 400 bp PCR products were gel purified and TA cloned into the
pCR 2.1 vector (Invitrogen). cDNA-containing plasmid was isolated and 50
clones/PCR reaction sequenced. Vb, Jb, and CDR3 were identified with
IMGT-V-Quest software (Immunogenetics Information System; http://www.
imgt.cines.fr). CDR3 charge and hydrophilicity analyses were performed with
the Innovagen peptide calculator (http://www.innovagen.se).
Cytokine Analysis
TCR-transduced 4G4.CD4 cells (1 3 105) were flow cytometrically sorted for
equivalent TCR expression levels and cultured in duplicate in the presence
of 3 3 105 APCs and the indicated stimulus. 100 ml of culture supernatant
was collected at 24 hr and analyzed for IL-2 by sandwich ELISA (BD PharMin-
gen) or Bio-Plex (Bio-Rad).
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One-factor ANOVA (GLM procedure, SAS, v9.1.3, SAS Institute Inc., Cary, NC)
was applied to compare three or more groups, and two-sample t test (TTEST
procedure, SAS) was applied to compare any two groups, if the data followed
a normal distribution. If the data were not normally distributed, the Kruskal-
Wallis test (NPAR1WAY procedure, SAS) was used to test differences among
three or more groups, and the Wilcoxon rank-sum test (NPAR1WAY proce-
dure, SAS) was used to compare the distribution between any two groups.
A nonparametric method (Kaigh and Cheng, 1991) was used to estimate
medians along with their 95% confidence intervals. A p value < 0.05 was
considered significant in all analyses. p values from parametric or nonpara-
metric tests were adjusted for multiple comparisons via the Hochberg method
(MULTTEST procedure, SAS). Means are displayed ±1 SD. Morisita-Horn
indices and abundance coverage estimator (ACE) analyses were calculated
with EstimateS software (Hsieh et al., 2006; Wong et al., 2007a, 2007b). The
upper limit of 95% confidence interval (CI) of the maximum frequency (4max)
of an unobserved TCR CDR3 transcript in a sample was calculated via the esti-
mation of binomial parameter (StatXact-8 8.0.0, Cytel Studio) and the upper
limit of 95% CI of the Blyth-Still-Casella estimation reported (Pacholczyk
et al., 2007).
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